How does prescribing for antihypertensive products stack up against guideline recommendations? An Australian population-based study (2006-2014).
about
Who benefits from fixed-dose combinations? Two-year statin adherence trajectories in initiators of combined amlodipine/atorvastatin therapy.Prior experience with cardiovascular medicines predicted longer persistence in people initiated to combinations of antihypertensive and lipid-lowering therapies: findings from two Australian cohorts.Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: A population-based retrospective cohort study.
P2860
How does prescribing for antihypertensive products stack up against guideline recommendations? An Australian population-based study (2006-2014).
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
How does prescribing for antih ...... ation-based study (2006-2014).
@en
How does prescribing for antih ...... tralian population-based study
@nl
type
label
How does prescribing for antih ...... ation-based study (2006-2014).
@en
How does prescribing for antih ...... tralian population-based study
@nl
prefLabel
How does prescribing for antih ...... ation-based study (2006-2014).
@en
How does prescribing for antih ...... tralian population-based study
@nl
P2860
P50
P356
P1476
How does prescribing for antih ...... lation-based study (2006-2014)
@en
P2860
P304
P356
10.1111/BCP.13043
P407
P577
2016-07-28T00:00:00Z